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Bipolar II (BP-II) depression is often misdiagnosed as unipolar (UP) depression, resulting in
suboptimal treatment. Tools for differentiating between these two types of depression are
lacking. This study aimed to develop a simple, self-report screening instrument to help distinguish BP-II depression from UP depressive disorder. A prototype BP-II depression questionnaire (BPIIDQ-P) was constructed following a literature review, panel discussions and a
field trial. Consecutively assessed patients with a diagnosis of depressive disorder or BP
with depressive episodes completed the BPIIDQ-P at a psychiatric outpatient clinic in Hong
Kong between October and December 2013. Data were analyzed using discriminant analysis and logistic regression. Of the 298 subjects recruited, 65 (21.8%) were males and 233
(78.2%) females. There were 112 (37.6%) subjects with BP depression [BP-I = 42 (14.1%),
BP-II = 70 (23.5%)] and 182 (62.4%) with UP depression. Based on family history, age at
onset, postpartum depression, episodic course, attacks of anxiety, hypersomnia, social
phobia and agoraphobia, the 8-item BPIIDQ-8 was constructed. The BPIIDQ-8 differentiated subjects with BP-II from those with UP depression with a sensitivity/specificity of 0.75/
0.63 for the whole sample and 0.77/0.72 for a female subgroup with a history of childbirth.
The BPIIDQ-8 can differentiate BP-II from UP depression at the secondary care level with
satisfactory to good reliability and validity. It has good potential as a screening tool for BP-II
depression in primary care settings. Recall bias, the relatively small sample size, and the
high proportion of females in the BP-II sample limit the generalization of the results.

Introduction
Bipolar disorder (BP) is a common psychiatric illness with a lifetime prevalence of approximately 5% in the general population [1, 2] and a point prevalence of 8–10% in primary care settings [3, 4]. In addition to immense suffering for patients and their relatives, BP incurs huge
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social and economic costs [5–7]. There is increasing evidence that BP is a very disabling illness
[8]. A systematic review of 34 papers found that the risk of suicide among BP patients is up to
20–30 times higher than that for the general population [9].
BP depression (BPD), in particular bipolar II disorder (BP-II), is frequently under- or misdiagnosed, mainly for unipolar depression (UPD) [9–12], resulting in suboptimal treatment and
poor outcomes [13–16]. Hypomanic symptoms are often neglected or mistaken as highly efficient behaviour or a manifestation of a particular personal style [17, 18].
Techniques to tease out BPD from UPD using fMRI, genetic testing and family studies are
being actively explored but remain insufficient [19–21], leaving clinical approaches as the main
type of investigation. Several questionnaires or diagnostic schedules targeting the detection of
BP have been developed. The Mood Disorder Questionnaire (MDQ) [9], Hypomania Checklist-32 [22] and Bipolar Disorder Screening Scale [23] all include only hypomanic cues for the
diagnosis of BP, but do not cater for BPD. The Bipolar Spectrum Diagnostic Scale (BSDS) [24]
does include depressive items but has poor positive predictive value [25]. The Bipolar Depression Rating Scale (BDRS) [26] is the only scale that measures BPD, but it is meant for rating
symptom severity in patients already diagnosed with BP rather than for detecting BPD.
As there are no clinical pathognomonic features for BPD, a probabilistic approach for diagnosing BP-I depression has been proposed, with operationalized criteria based on a literature review
and ‘clinical reasonability’ [27, 28]. However, no corresponding instrument exists for the diagnosis
or screening of BP-II depression, and thus the development of such an instrument is imperative.
This study aimed to develop a brief self-report screening tool for BPD, with discriminant
validity against UPD and predictive validity for evolution into full-blown bipolar disorder. As
BP-I and BP-II depression present differently [29–31], and BP-II represents the more cryptic but
relatively well-defined component of the BP spectrum [1, 2], it was decided that BP-II depression
should constitute the main theme of the investigation. The ultimate goal was to develop a screening tool that is brief and simple enough that it can be used in psychiatric outpatient clinics, and
even in primary care settings where potential patients abound and expertise is lacking.

Methods
Development of the self-report screening tool–Bipolar II Depression
Questionnaire (BPIIDQ)
Literature search. The phenomenology and historical development of the concepts of
UPD and BPD [32, 33] were reviewed. Features related to their differences and also those
between BP-I and BP-II [34–36] were scrutinized.
Inclusion of items. Atypical features associated with BPD such as hypersomnia and appetite increase (DSM IV-TR 2000) [37], suicide attempts [38], family history of BP or completed
suicide [39], young age at onset [40], recurrent course [41], post-partum presentation [34],
mixed state [17], phobic and obsessive symptoms [39] and substance abuse [42] were considered.
Exclusion of items. Hypomanic cues and those more related to BP-I than BP-II, such as a
history of hospital admission and psychosis [42, 43], were filtered out. Three other potential
items were excluded: history of suicide attempts was excluded because the validity of selfreports can be limited [44], substance abuse because of its low incidence in the Hong Kong
Chinese population [45] and psychomotor retardation because it cannot be readily observed
during a relatively brief outpatient visit.
Devising the text. Features considered specific to BP-II depression were phrased in modern Chinese, with simplicity and brevity emphasized. The text was further checked linguistically by two bilingual experts in Cantonese and Mandarin Chinese (CY and YTX). The first
version was named the Bipolar II Depression Questionnaire-Prototype (BPIIDQ-P).
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Pilot study and text revision. A pilot study was conducted with 10 BPD and 10 UPD subjects who completed the BPIIDQ-P. All subjects had a history of depressive episodes and were in
full remission. Following the pilot study, the questionnaire was further edited to reduce ambiguity.
Field work. The main part the study was conducted between October and December 2013
in the psychiatric service of Shatin Hospital, which serves a population of approximately
500,000. Within the study period, all ethnic Chinese outpatients attending the clinical team of
the principal investigator (CML) aged 18–65 years and diagnosed with a DSM-IV depressive disorder (including BP with a history of depressive episode, major depressive disorder (MDD) and
dysthymia (DYS), were consecutively recruited. In each individual case, the clinical diagnosis was
made independently by two psychiatrists (CML and CLY). The principal investigator personally
followed all of the cases over many years and made diagnoses based on thorough clinical assessments. The other psychiatrist (CLY) made the diagnoses by reviewing the case records. Joint
interviews were conducted to resolve diagnostic disagreements. In unresolved cases, a third assessor (CCC) independently administered the Structured Clinical Interview for DSM-IV Disorders
(SCID-DSM-IV) [46, 47] to reach a final diagnosis. All three assessors were blind to the results of
the BPIIDQ-P. Patients with significant cognitive impairment, e.g. severe learning disability,
dementia or cognitive deficits associated with brain damage, and unstable mental state, e.g. severe
depression or psychosis, that jeopardized accurate self-report were excluded.
The subjects completed the BPDIIQ-P and the Hospital Anxiety and Depression Scale
(HADS) [48, 49] to measure the severity of depressive symptoms. Forty randomly selected subjects repeated the BPDIIQ-P two weeks later, to measure test-retest reliability. Relevant demographic and clinical data were retrieved from case records and the hospital’s computer system.
History of suicide attempts, defined by O’Carroll [50], was further confirmed with the respective subjects at follow-up sessions.
The study protocol was approved by the Joint Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee. Written informed consent was
obtained from each participant. All information was kept in a computer protected by a password. Only the PI (CML) and co-Investigators have access to the data.

Statistical analysis
Data were analyzed using the Statistical Package for Social Sciences (SPSS) Version 19. The
MDD group was divided into recurrent depressive disorder (RDD) and major depressive episode, which was further subdivided into with psychosis i.e. psychotic depression (PD), and
without (MDE). Priority in categorization was given to recurrence over presence of psychosis,
as in DSM-IV. Categorical variables were analyzed using chi-square, non-parametric continuous data with Mann Whitney U and continuous variables with Student’s t-test. The significance level was set at 0.05. Discriminant analysis was used to extract the best combination of
items for differentiating between BP-II and UP. One-step forward selection binary logistic
regression was performed to check for the odds ratios and independence of significant items.
Items were weighted according to the odds ratios. Different scoring methods were explored
with ROC curves to obtain the best cut-off points with optimal sensitivity and specificity.
Exploratory factor analysis was performed with the final version of the BPIIDQ-P.

Results
Bipolar depression questions
The BPIIDQ-P consists of 13 bipolar depression questions (bdq) grouped into 2 sections (S1
Table). Section A comprises three questions about the patient’s personal and family history,
bdq1 (positive family history), bdq2 (onset before 25) and bdq3 (postpartum depression).
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Section B comprises 10 questions about the course of the illness and symptoms, bdq4 (episodic
course), bdq5 (endogeneity), bdq6 (fatigue), bdq7 (panic attacks), bdq8 (social phobia), bdq9
(emotional numbness), bdq10 (hypersomnia), bdq11 (sense of uselessness), bdq12 (agoraphobia) and bdq13 (obsessive ruminations).

Demographic and clinical data
A total of 320 BP and UP subjects attended the clinic during the study period. Sixteen subjects
were excluded for unstable mental state and 6 declined to participate. Thus, 298 subjects
entered the study, giving a response rate of 93%. There was no significant difference in age and
sex between the excluded and included patients. Initial diagnostic disagreement between the
two psychiatrists occurred in 27 (9.1%) subjects. Following a joint interview, consensus was
reached in 22 cases, leaving 5 for final decision by SCID-assisted interview. The demographic
and clinical data are presented in Table 1.

Discriminant analysis
The results of the discriminant analysis are shown in Table 2. To maximize the number of
valid cases, bdq3 –referring to postpartum depression in women–was omitted from the analysis. Bdq1 (positive family history), bdq2 (onset < 25), bdq4 (episodic course) and bdq10
(hypersomnia) were significant independent predictors (p < .05). Bdq7 (panic attacks), bdq8
(social phobia), bdq12 (agoraphobia) and bdq13 (obsessive ruminations) were positively correlated with the discriminant function, but failed to reach statistical significance. These four
items helped to maximize the discrimination of BP-IID from UPD. Bdq5 (endogeneity), bdq6
(fatigue), bdq9 (emotional numbness) and bdq11 (sense of uselessness) were weakly or negatively correlated with the discriminant function of the scale.
Table 1. Demographic and clinical data of the study sample.
BP-IID

BP-ID

UPD

70

42

186

Subjects

BP-IID vs UPD

BP-IID vs BP-ID

Psychiatric diagnosis
RDD

63 (33.9%)

MDE

62 (33.3%)

PD

17 (9.1%)

DYS

44 (23.7%)

M/F

15/55

19/23

31/155

NS

P < .01

Age

47.0 ± 11.2

44.1 ± 9.5

46.8 ± 10.5

NS

NS

Education (yr)

11.3 ± 3.0

12.2 ± 3.4

10.2 ± 3.2

NS

NS

Duration of illness (yr)

13.6 ± 7.7

17.6 ± 9.2

9.2 ± 7.2

NS

NS

Suicide attempt
HADS score

27.7%

25.6%

26.8%

NS

NS

8.3 ± 5.5

5.7 ± 4.7

10.0 ± 4.6

p = .05

NS

BP-ID = Bipolar I depression
BP-IID = Bipolar II depression
UPD = Unipolar depression
RDD = Recurrent depressive disorder
MDE = Major depressive episode
PD = Psychotic depression
DYS = Dysthymia
doi:10.1371/journal.pone.0149752.t001
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Logistic regression
The results of the chi-square tests used to test the bdq items that differentiated BP-IID from
other depressive disorders and BP-I (p < .05) are shown in Table 3. Bdq items 1, 2, 4 and 10
individually discriminated BP-IID from UPD, with odds ratios of 3.47, 2.00, 2.09 and 2.36,
respectively. In the logistic regression, only one item, bdq1 (positive family history), differentiated between the two groups of disorders (p < .000, Exp (B) 5.93, 95% Cl 2.44–14.37).

The 8-item Bipolar II Depression Questionnaire
Components and scoring methods, sensitivity and specificity. Based on the results of
the discriminant analysis and chi-square test results, bdq items 1, 2, 4 and 10, together with
bdq items 3 (postpartum depression), 7, 8, 12 and 13 (panic attacks, social phobia, agoraphobia
and obsessive rumination, respectively) constituted the final BPIIDQ, with scoring of individual items weighted according to the odds ratios of the respective items. ROC curves were used
to explore different combinations of items and weights for optimal sensitivity and specificity
(Fig 1A and 1B). The best scoring method was achieved by summing bdq1 x 3, bdq2 x 1, bdq4
x 2, bdq10 x 2, bdq7 x 1, bdq8 x 1 and bdq12 x 1 (7 items), which gave an optimal sensitivity of
0.75 (95%CI 0.62–0.85) and specificity of 0.63 (95%CI 0.55–0.70) (AUC = 0.72), with a cut-off
point of 7/8 for the whole sample (Fig 2A). The same scoring method including bdq3 x 1 (8
items) gave an optimal sensitivity of 0.77 (95%CI 0.57–0.89) and specificity of 0.72 (95%CI
0.62–0.80) (AUC = 0.72), with a cut-off point of 8/9 for females with a history of childbirth
(Fig 2B). The 8-item BPIIDQ (BPIIDQ-8) and its scoring method are shown in S2 Table.
Internal consistency and test-retest reliability. Cronbach’s alpha for the BPIIDQ-8 was
0.60. The mean test-retest reliability coefficient was 0.66 at 2 weeks, with individual values of
bdq1 = .85, bdq2 = .55, bdq3 = .82, bdq4 = .39, bdq7 = .76, bdq8 = .46, bdq10 = .90 and
bdq12 = .61. The item probing the recurrent nature of BP-II, bdq4, had the lowest score.
Item combinations with best specificity. Disregarding sensitivity, the different combinations of bdq items that yielded the best specificity are listed in Table 4. The four bdq items 1, 2,
Table 2. Discriminant analysis for differentiating BP-IID from UPD.
Standardized function coefﬁcients

Correlations between variables and discriminant function

bdq1 (positive family history)

.567*

.621

bdq2 (onset <25)

.324*

.409

bdq4 (episodic course)

.514*

.396

bdq7 (panic attacks)

.143

.181

bdq8 (social phobia)

.008

.199

.408*

.358

bdq12 (agoraphobia)

.173

.264

bdq13 (obsessive rumination)

.175

.132

bdq5 (endogenicity)
bdq6 (fatigue)

bdq9 (emotional numbness)
bdq10 (hypersomnia)
bdq11 (sense of uselessness)

Negative values were omitted
*signiﬁcant predictor
BP-IID = Bipolar II depression
UPD = Unipolar depression
bdq = Bipolar depression question
doi:10.1371/journal.pone.0149752.t002
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Table 3. Items of the BPIIDQ-8 differentiating BP-II from UPD and its subgroups.
bdq item
BP-II vs

UP

1, 2, 4, 10

RDD

8, 10#

MDE

1, 2, 4, 10, 12#

PD

1, 2, 4

DYS

1, 2, 7#, 10

chi square, p < .05; #p = .06
BP-IID = Bipolar II depression
UPD = Unipolar depression
RDD = Recurrent depressive disorder
MDE = Major depressive episode
PD = Psychotic depression
DYS = Dysthymia
bdq = bipolar depression question
bdq1 = “positive family history” bdq7 = “panic attacks”
bdq2 = “onset <25” bdq8 = “social phobia”
bdq3 = “postpartum depression” bdq10 = “hypersomnia”
bdq4 = “episodic course” bdq12 = “agoraphobia”
doi:10.1371/journal.pone.0149752.t003

Fig 1. 1a. ROC curves for different combinations of bdq items (all cases). Fig 1b. ROC curves for different combinations of bdq items (females with history of
childbirth).
doi:10.1371/journal.pone.0149752.g001
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Fig 2. 2a. ROC curve for the 8-item BPIIDQ (all cases). Fig 2b. ROC curve for the 8-item BPIIDQ–(females with history of childbirth).
doi:10.1371/journal.pone.0149752.g002

4 and 10 yielded a specificity of 0.90 in differentiating BP-IID from UPD, while the best specificity obtained with the minimum number of items was 0.92, with bdq1, 2, 4, 10 and 3 (postpartum depression as an addition).
Factor analysis. Factor analysis of the BPIIDQ-8 with Varimax rotation yielded three factors with Eigenvalues above one, accounting for 56.0% of the variance (Fig 3 and Table 5).
Table 4. Bipolar depression question item combinations yielding best specificity.
Speciﬁcity with items scoring positive
No. of items

Best bdq combination

BP-IID against UPD

1

1

0.63

2

1, 2

0.82

3

1, 2, 10

0.87

4

1, 2, 10, 4

0.90

5

1, 2, 10, 4, 3

0.92

6

1, 2, 10, 4, 3, 7

0.92

7

1, 2, 10, 4, 3, 7, 8

0.92

bdq = bipolar depression question
bdq1 = “positive family history”
bdq2 = “onset <25”
bdq3 = “postpartum depression”
bdq4 = “episodic course”
bdq7 = “panic attacks”
bdq8 = “social phobia”
bdq10 = “hypersomnia”
doi:10.1371/journal.pone.0149752.t004
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Fig 3. Scree plot for BPIIDQ-8.
doi:10.1371/journal.pone.0149752.g003

Discussion
To the best of our knowledge, this study was the first to develop a self-report questionnaire to
screen for BP-IID. Investigations that do not distinguish between BP-I and II often yield confusing results. A clinically significant conversion rate from UPD to BP and from BP-II to BP-I
Table 5. Rotated component matrix of BPIIDQ-8.
Component
1

2

bdq1

.430

bdq2

.683

bdq3

.785

bdq4

3

.911

bdq7

.546

bdq8

.806

bdq10

.659

Bdq12

.741

BPIIDQ-8 = 8-item Bipolar II Depression Questionnaire
bdq1 =“positive family history” bdq7 =“panic attacks”
bdq2 =“onset <25” bdq8 =“social phobia”
bdq3 =“postpartum depression” bdq10 = “hypersomnia”
bdq4 =“episodic course” bdq12 =“agoraphobia”
doi:10.1371/journal.pone.0149752.t005
PLOS ONE | DOI:10.1371/journal.pone.0149752 March 10, 2016
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[22, 51–53] adds to the confusion. Among the major subtypes, BP-II most easily escapes detection because it cannot be fully confirmed without a definite hypomanic swing that may only
emerge over time. The fact that hypomanic episodes in depressed patients are not always correctly identified by clinicians is another reason. In view of the high rate of misdiagnosis and
high prevalence of BP-II in the community, this study aimed to construct a simple self-report
tool with a reasonable degree of reliability and validity to screen for patients at high risk of
developing BP-IID in outpatient settings, including primary care.
Much difficulty was encountered in designing the first four items of the BPIIDQ-P when
building the primary test. Item 1 probes for a family history of mood or BP disorder. It was
phrased as ‘having a first-degree relative who received psychiatric treatment or died of suicide’.
Alternative phrasing, such as a family history of mental illness or mood disorder, was considered too ill-defined, whereas bipolar disorder or mania were considered too specific, particularly in cultures where mental illness is associated with a strong social stigma. Furthermore,
misdiagnosis of bipolar disorder as schizophrenia is not uncommon [54]. The chosen phrasing
was considered the best compromise with regards to emphasizing familial clustering of mental
disorders and suicide in BP-II [41]. Item 2 probes for the age at onset. Most studies put the
mean age of onset of BP-II at 20 to 25 [1, 55]. The higher end of the range, 25 years, was chosen
to increase the sensitivity and minimize contamination by adolescent turmoil. This cut-off for
age at onset is also in line with what has been proposed to differentiate between BP and UPD
[27, 56]. Item 3 probes for postpartum depression with the simple statement, “You suffered
from postpartum depression”. The severity of the condition is deliberately not qualified, so as
to enhance the sensitivity of the question and allow subjects to make their own interpretation.
As postpartum mood disorders could be easily missed as postpartum blues [57], respondents’
subjective experience could be a more sensitive guide than a history of medical consultation.
Item 4 probes for the episodic nature of BP-II, which most respondents found difficult to recognize, either because they did not have the experience, or because long-lasting low grade fluctuations have become part of their lives. Their uncertainty is reflected in the low test-retest
reliability of the response.
Items probing family history, onset before age 25, episodic course and hypersomnia differentiated BP-IID from UPD with p < .05. These differentiating factors are well documented
[35, 39] and form the “core” items of the BPIIDQ. Family history of psychiatric treatment or
suicide was the only independent predicting or differentiating factor and was identified as the
“essential” item. The other items, postpartum depression, panic attacks, social phobia and agoraphobia, that did not distinguish BP-IID from UPD, were designated as ‘accessory’ items. As
the constitution of UPD subgroups varies from sample to sample, these “accessory” items were
retained in the final version of the questionnaire as guided by the discriminant analysis. They
proved to be useful in making the questionnaire more sensitive and specific (Fig 1A and 1B).
BP-IID was similar to recurrent UPD in terms of family history and age at onset, in addition
to the recurrent or episodic course. This highlights the unique status of recurrent UPD in relation to BP-II, with its bipolar “flavour” and its difference from other forms of UPD [41, 58].
Although BP-II and BP-I are both classified as BP, the former has been associated with a stronger family history and higher incidence of postpartum depression [21, 59, 60].
In agreement with some [38] but not most [31, 39] findings, no difference was found in the
incidence of suicide attempts between BPD and UPD, or between BP-I and BP-II. In addition
to sampling and cultural differences across studies, varying definitions of suicide attempts and
different ways of collecting information may explain the conflicting results. These findings and
considerations justify omitting suicide attempts as a discriminating feature between BP-IID
and UPD.
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After repeated trials, the BPIIDQ-8, with appropriate weighting factors and adjustment,
gave an optimal sensitivity of 77% and specificity of 72% at the cut-off point of 8/9 for females
with a history of childbirth. With the postpartum item taken out, the questionnaire yielded a
sensitivity of 75% and specificity of 63% at the cut-off point of 7/8 for the whole sample. The
psychometric properties of the BPIIDQ-8 are considered satisfactory as a screening tool for
specific psychiatric diagnoses [61], thus its external validity is established.
Subgroups such as females without a history of childbirth and males were not treated separately. The former presented with a less satisfactory ROC curve, probably due to their younger
age and shorter duration of illness, while the latter comprised a small sample size. With bdq1
(family history) or bdq1 and bdq2 (family history, and onset before 25), the specificity was 66%
and 83%, respectively, making it a very simple and easy way to assess the probability of a
BP-IID in primary care. If all of the core items, bdqs 1, 2, 4 and 10, score positive, the specificity
reaches 89%. The mnemonic ‘FARS’ standing for Family history, Age at onset, Recurrent
course and Sleeping too much, could be an easy way to remember.
Apart from satisfactory sensitivity and specificity, BPIIDQ-8 has excellent construct validity, with factor analysis showing three factors with Eigenvalues above one. The first is the
“symptom” factor as it contains the classic symptoms of BP-IID including anxiety, hypersomnia and social and agoraphobia. The second is the “biological” factor as it contains items on
genetic loading, age at onset and postpartum presentation, thus signifying the possible biological nature of BP-IID. The third factor contains only one item, the “course” factor, which
describes the cyclical or episodic nature of BP-II. This agrees well with the theoretical construct
as originally conceived.

Limitations of the study
This study has a number of limitations, the intrinsic one being related to the self-report nature
of the BPIIDQ. Further, patients with a history of suicide attempts were excluded because of
the low validity of self-report measures [44]. Because suicide attempts are fundamental indicators of BP, strict definitions of suicide attempts should be used in future studies. Recall bias
could have been aggravated by current mood disturbances [62, 63], although care was exercised
to exclude respondents with significant depressive symptoms. Past experiences such as age at
onset and the episodic course of the illness may have been inconsistently reported, as evidenced
by their relatively low test-retest reliability.
Another limitation inherent in any study of BP arises from the spectrum nature of BP. UPD
is also heterogeneous. The label of UPD is provisional and revised to BP when a history of
hypomania is revealed or a hypomanic episode newly emerges. This makes the boundary
between BP and UPD indistinct at the clinical level, a fact that undermines the very goal of this
study, although great efforts were made to ensure the accuracy of the diagnoses by long-term
follow-up and using multiple independent assessors.
The relatively small sample size of only 70 BP-II subjects represents another major drawback, as larger samples would have been needed to clarify the significance of minor differences.
This is especially true with the diagnostic value of postpartum depression, as Hong Kong has
one of the lowest fertility rates in the world and local women conceive late [64]. A further limitation was that the sample did not include subjects with the diagnostic category of Depression
NOS or mixed depression. Mixed depression, defined as depression with symptoms of excitement, is common in both BP and UPD, and is usually associated with antidepressant treatment
[65]. For logistical reasons data on the history of and current psychotropic drug treatment
were not recorded. The sample was significantly sex-biased, comprising predominantly
females. Female predominance in mood disorders is universal but such a high ratio in BP-II is
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unexpected [66–68]. Under-diagnosis in males and their reluctance to seek help to save face in
a paternalistic Chinese society may explain the phenomenon. Finally, the study was conducted
at a specialist centre, thus the results may not be generalizable to other settings. The threshold
or cut-off points on the scale will need further investigation if used in different cultures.

Strength of the questionnaire
The inclusion of items was guided by a literature review and adjusted on the basis of statistical
analyses. The BPIIDQ-8 is a self-report, single sheet, paper and pencil test that can be completed in 1–2 minutes. Its validation in different types of mood disorder was explored both
cross-sectionally and longitudinally against best estimate lifetime diagnoses made by two experienced psychiatrists. Subjects with doubtful diagnoses were independently scrutinized by
another psychiatrist using the SCID [9]. The cut-off points were based on optimal sensitivity
and specificity assessed by ROC curves [27].

Conclusions
BP-II is a distinct subgroup of the mood disorder spectrum that poses a diagnostic challenge in
both psychiatric and primary care settings. The BPIIQQ-8 is a simple instrument that is able to
differentiate BP-IID from UPD with satisfactory sensitivity and specificity. It has good potential as a screening tool for BP-IID in psychiatric outpatient clinics and even in primary care.
Although not diagnostic in its own right, a positive result is an indication of the need for more
thorough evaluation of BPD.
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